Endoscopic skull base/sinonasal adenocarcinoma surgery: What evidence exists?

Background: This study reviewed the published outcomes literature on endoscopic or endoscopic-assisted treatment of sinonasal and skull base adenocarcinoma (SSBA) A systematic literature review was performed Methods: A Pub Med search of English language articles on endoscopic or endoscopic-assisted SSBA was performed Each article was examined for patient data and outcomes for analysis Results: Sixteen articles (150 retrospective cases) using endoscopic or endoscopic-assisted SSBA were identified Three (19%) reported at least15 cases of adenocarcinoma with 5-year survival ranging from 53 to 83% In all identified studies, five (31%) reported adenocarcinoma-specific survival statistics and eight (50%) provided complete patient information Adjuvant therapy was used in 12 studies (75%), with details outlined in 6 (38%) articles, accounting for 52 of 74 cases (70% of those patients and 35% overall) Adenocarcinoma-specific follow-up was reported in only nine studies (56%), four of these nine articles had a median/mean follow-up tone of <3 years Six articles (38%) used American joint Committee on Cancer guidelines and fur articles (25%) used International Union Against Cancer guidelines The remaining six articles (38%) did not report on the stage of treated tumors Four articles (25%) reported length of hospital stay and eight (50%) reported complication data Three studies comprising 61 cases (41% of overall patients) recorded disease status, tumor stage, site involvement, and complication rates for each patient Conclusion: From the existing body of data, one can not conclude that endoscopic methods are superior or inferior to open methods, but there is growing evidence that this is an efficacious technique Future studies should have emphasis on detailed, prospective reporting (Am J Rhinol Allergy 24, 156-160, 2010, doi 10.2500/ajra.2010.24.3449)